Chief of the LCS, a position he held with distinction until 1983. He led the lab during the early days of neuropsychopharmacology, side by side with luminaries such as Julius Axelrod. With Axelrod and others, Kopin published numerous original research articles dealing with the disposition and metabolism of catecholamines. He first proposed the notion of false neurotransmitters, a chemical compound that mimics the action of a neurotransmitter. He also showed that the chemical 1-methyl-4-phneyl-1,2,5,6-tetrahydorpyridine (MPTP) rapidly produces a 'time-telescoped' form of Parkinson's disease. This finding
wouldn't ever contradict himself. His intelligence came out in interesting ways. For example, he was in charge of controlled substances in NINDS which were kept in a safe. When he went on vacation, I (DSJ) was his deputy, so I had to know how to open the safe. The code was the first part of the 'Fibonacci sequence. ' Kopin was a mentor and role model for scores of postdoctoral researchers, many of whom now occupy key positions in academic medicine or the pharmaceutical industry. One of us, Dr David S Goldstein, whom he supervised and mentored for over 35 years, remembers their typical style of communication was debate, in the Talmudic tradition of the 'chevrusah,' or learning partner. Goldstein recalls, 'Together we argued about interpretations of the data, experiments that should be done, conceptual models, getting the historical facts straight, and most recently about how to link genetics and molecular biology with integrative physiology. I look at his empty desk in the lab and while of course saddened, I also feel thankful and honored that he was my medical scientific chevrusah for so many years. ' Kopin is survived by his wife Rita, son Alan, daughters Gail and Judye, and eight grandchildren. Memorial contributions may be made to Congregation Beth El, the Dana-Farber Cancer Institute, or to MAZON-a Jewish response to hunger.
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